热门资讯> 正文
Seres Therapeutics宣布领导层交接
2025-07-22 19:57
- Seres医疗(MCRB) 0
- 纳比特(NA) 0
- 盛大科技(SDA) 0
- Seres Therapeutics (NASDAQ:MCRB) appointed Thomas DesRosier and Marella Thorell as co-Chief Executive Officers.
- This appointment will follow the departure of CEO Eric Shaff on July 31, 2025, after a decade with the company, to pursue a new professional opportunity.
- Mr. Shaff will continue to serve as a Director on the Seres Board.
- Mr. DesRosier and Ms. Thorell will retain responsibilities related to their roles as chief legal officer and CFO, respectively.
More on Seres Therapeutics
- Seres Therapeutics, Inc. (MCRB) Q1 2025 Earnings Call Transcript
- Seeking Alpha’s Quant Rating on Seres Therapeutics
- Historical earnings data for Seres Therapeutics
- Financial information for Seres Therapeutics
推荐文章
市值破4万亿美元的微软涨势未止! Microsoft365 涨价浪潮强化“增长叙事”
半年狂赚22亿元，老铺黄金股价31天内跌了22天
美联储纪要偏鹰！多数官员视通胀为更大风险，降息预期降温对市场影响几何？新浪财经深度解析
谁会成为下任美联储主席？经济学家预测：特朗普将选择最忠诚的他…
华盛早报 | 降息悬了？美联储7月会议仅两位官员支持降息；港交所将研究24小时交易机制
“AI大牛股”Palantir遭遇“黑色一周”！空头绝处逢生狂揽数十亿美元
重磅预期催化！港交所将研究24小时交易机制 券商板块迎价值重估（附概念股）
华尔街分析师大胆预测：2030年英伟达市值将达9万亿美元，年收入将达6000亿美元
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
